Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Inhalant Mammal-Derived Lipocalin Allergens and the Innate Immunity.

Frontiers in allergy·2022

Same author

Single-cell characterization of dog allergen-specific T cells reveals T<sub>H</sub>2 heterogeneity in allergic individuals.

The Journal of allergy and clinical immunology·2021

Same author

Associations Between Neonatal Cry Acoustics and Visual Attention During the First Year.

Frontiers in psychology·2020

Same author

Commentary: Allergen and Epitope Targets of Mouse-Specific T Cell Responses in Allergy and Asthma.

Frontiers in immunology·2019

Same author

Improving competing voices segregation for hearing impaired listeners using a low-latency deep neural network algorithm.

The Journal of the Acoustical Society of America·2018

Same author

Reply to the letter to the editor concerning the review Immunotherapy for pet allergies.

Human vaccines & immunotherapeutics·2018

Search research articles

Related Experiment Video

Updated: Jul 19, 2026

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

Prospects for peptide-based immunotherapy for dog allergy.

Tuomas Virtanen¹

¹Department of Clinical Microbiology, University of Kuopio, Harjulantie 1 B (POB 1627), FIN-70211 Kuopio, Finland. tuomas.virtanen@uku.fi

Current Opinion in Allergy and Clinical Immunology

|November 8, 2006

Summary

Specific immunotherapy using allergen peptides can induce tolerance to dog allergens. A pool of seven peptides targeting Can f 1 epitopes shows promise for treating dog allergy, especially in Caucasian populations.

More Related Videos

Intralymphatic Immunotherapy and Vaccination in Mice

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Saline Lavage for Sampling of the Canine Nasal Immune Microenvironment

Saline Lavage for Sampling of the Canine Nasal Immune Microenvironment

Published on: December 27, 2024

Related Experiment Videos

Last Updated: Jul 19, 2026

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

Intralymphatic Immunotherapy and Vaccination in Mice

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Saline Lavage for Sampling of the Canine Nasal Immune Microenvironment

Saline Lavage for Sampling of the Canine Nasal Immune Microenvironment

Published on: December 27, 2024

Area of Science:

Immunology
Allergology
Biochemistry

Background:

Allergies to common environmental substances like pet dander necessitate effective treatments.
Specific immunotherapy offers a way to induce tolerance to allergens.
Dog allergens are prevalent indoor allergens, driving the need for targeted therapies.

Purpose of the Study:

To review current approaches for dog allergy immunotherapy.
To evaluate the potential of peptide-based immunotherapy for dog allergy.

Main Methods:

Identification of human T-cell epitopes of the major dog allergen, Can f 1.
Design of a peptide pool comprising seven peptides, each from a distinct epitope region of Can f 1.

Main Results:

The major dog allergen Can f 1 has seven identified T-cell epitope regions.
A pool of seven peptides derived from these regions is proposed as a therapeutic strategy for dog allergy.
The immunodominance of Can f 1 suggests potential need to include other dog allergens in future peptide pools.

Conclusions:

A peptide pool targeting Can f 1 T-cell epitopes is a feasible approach for treating dog allergy in most Caucasian individuals.
Future research may focus on patient-tailored peptide variants to improve immunotherapy efficacy.